Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett P Monia

Showing results (41-50 of 147) with videos related to

Pageof 15
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 12, 2011
Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosisBarbara Kluve-Beckerman, Joyce Hardwick, Lijing Du, et al.
Molecular Pharmacology|August 24, 2004
Effects of antisense oligonucleotide-mediated depletion of tumor necrosis factor (TNF) receptor 1-associated death domain protein on TNF-induced gene expressionAndrew M Siwkowski, Lisa A Madge, Seongjoon Koo, et al.
Nucleic Acid Therapeutics|April 16, 2013
Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12Gourab Bhattacharjee, Alexey S Revenko, Jeffrey R Crosby, et al.
American Journal of Respiratory and Critical Care Medicine|December 25, 2004
Bcl-2 sustains increased mucous and epithelial cell numbers in metaplastic airway epitheliumJ Foster Harris, Mark J Fischer, Jon R Hotchkiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamideChristiane Thallinger, Markus F Wolschek, Helmut Maierhofer, et al.
Biochemical Pharmacology|May 15, 2002
Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-jun antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotypeBin Pan, Kang Shen Yao, Brett P Monia, et al.
Blood|February 7, 2014
Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbitsJonathan W Yau, Peng Liao, James C Fredenburgh, et al.
Journal of Lipid Research|January 24, 2007
Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic miceMark J Graham, Kristina M Lemonidis, Charles P Whipple, et al.
The Journal of Clinical Investigation|March 26, 2013
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in miceShuling Guo, Carla Casu, Sara Gardenghi, et al.
Human Molecular Genetics|December 24, 2016
Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell linesGregory P Holmes-Hampton, Daniel R Crooks, Ronald G Haller, et al.
Pageof 15

Showing results (41-50 of 147) with videos related to

Sort By:
Pageof 15
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 12, 2011
Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosisBarbara Kluve-Beckerman, Joyce Hardwick, Lijing Du, et al.
Molecular Pharmacology|August 24, 2004
Effects of antisense oligonucleotide-mediated depletion of tumor necrosis factor (TNF) receptor 1-associated death domain protein on TNF-induced gene expressionAndrew M Siwkowski, Lisa A Madge, Seongjoon Koo, et al.
Nucleic Acid Therapeutics|April 16, 2013
Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12Gourab Bhattacharjee, Alexey S Revenko, Jeffrey R Crosby, et al.
American Journal of Respiratory and Critical Care Medicine|December 25, 2004
Bcl-2 sustains increased mucous and epithelial cell numbers in metaplastic airway epitheliumJ Foster Harris, Mark J Fischer, Jon R Hotchkiss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Mcl-1 is a novel therapeutic target for human sarcoma: synergistic inhibition of human sarcoma xenotransplants by a combination of mcl-1 antisense oligonucleotides with low-dose cyclophosphamideChristiane Thallinger, Markus F Wolschek, Helmut Maierhofer, et al.
Biochemical Pharmacology|May 15, 2002
Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-jun antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotypeBin Pan, Kang Shen Yao, Brett P Monia, et al.
Blood|February 7, 2014
Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbitsJonathan W Yau, Peng Liao, James C Fredenburgh, et al.
Journal of Lipid Research|January 24, 2007
Antisense inhibition of proprotein convertase subtilisin/kexin type 9 reduces serum LDL in hyperlipidemic miceMark J Graham, Kristina M Lemonidis, Charles P Whipple, et al.
The Journal of Clinical Investigation|March 26, 2013
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in miceShuling Guo, Carla Casu, Sara Gardenghi, et al.
Human Molecular Genetics|December 24, 2016
Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell linesGregory P Holmes-Hampton, Daniel R Crooks, Ronald G Haller, et al.
Pageof 15